Skip to main content
TipRanks
Go Ultimate75% OFF

Andrew John Sneddon Insider Profile

4 Followers

Andrew John Sneddon, Director at Amplia Therapeutics, holds 364.89K shares in Amplia Therapeutics (Ticker: INNMF). Most recently, Andrew John Sneddon Sold 611,111 shares of Amplia Therapeutics on Aug 08, 2017 for an estimated value of $27.50K.

Andrew John Sneddon's Trading History

INNMF
Amplia Therapeutics
Aug 08, 2017DirectorInformative Sell27.50K$19.34K
INNMF
Insider Shares: 364.89K (16.17%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 08, 2017Informative SellAU$27.50K611,111AU$0.04+37.80%―
Sep 12, 2016Informative BuyAU$37.64K110,701AU$0.34-90.70%―
Jul 14, 2016Informative BuyAU$15.28K61,111AU$0.25-84.30%―
Mar 09, 2016Informative BuyAU$9.50K50,000AU$0.19+331.20%―
Mar 02, 2016Informative BuyAU$37.96K200,000AU$0.19+238.50%―

You May Also Like

Andrew John Sneddon insider profile FAQ

What is the percentage of profitable transactions made by Andrew John Sneddon?
The percentage of profitable transactions made by Andrew John Sneddon is 60%.
What is the average return per transaction made by Andrew John Sneddon?
The average return per transaction made by Andrew John Sneddon is 86.50%.
What stocks does Andrew John Sneddon hold?
Andrew John Sneddon holds: INNMF stocks.
What was Andrew John Sneddon’s latest transaction?
Andrew John Sneddon’s latest transaction was an Informative Sell of $27.50K.
What was Andrew John Sneddon's most profitable transaction?
Andrew John Sneddon’s most profitable transaction was an Informative Buy of INNMF stock on March 9, 2016. The return on the trade was 331.20%.
What is Andrew John Sneddon's role in Amplia Therapeutics?
Andrew John Sneddon's role in Amplia Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.